文献速递神经肿瘤

原发性与复发性胶质母细胞瘤的定量蛋白质组景观揭示FBXO2依赖性胶质瘤-微环境相互作用的促肿瘤作用

Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions.
PubMed 文献 · Neuro Oncol · 2023-01-01

本研究采用SWATH-MS技术对两个独立队列的配对初诊与复发胶质母细胞瘤进行定量蛋白质组分析,发现BCAS1、INF2和FBXO2在复发时持续上调并经免疫组化验证。FBXO2敲除在原位异种移植小鼠模型中带来强烈生存获益,并减少脑片培养中的侵袭性生长。FBXO2在肿瘤浸润区富集,其阳性癌细胞与突触信号过程相关,提示FBXO2依赖性胶质瘤-微环境相互作用可能促进肿瘤生长。

要点

  • SWATH-MS分析配对初诊与复发胶质母细胞瘤,鉴定BCAS1、INF2和FBXO2在复发时持续上调并经免疫组化验证。
  • FBXO2敲除在原位异种移植小鼠模型中带来强烈生存获益,并减少脑片培养中的侵袭性生长。
  • FBXO2在胶质母细胞瘤患者样本的肿瘤浸润区富集,FBXO2阳性癌细胞与突触信号过程相关。

核心结论

  • 这些发现表明FBXO2依赖性胶质瘤-微环境相互作用可能具有促进肿瘤生长的作用。
  • 已发表的数据集为进一步研究提供了宝贵资源。

研究设计与样本

  • 采用SWATH-MS(Sequential window acquisition of all theoretical fragment ion spectra mass spectrometry)表征两个独立队列的配对初诊与复发胶质母细胞瘤的定量蛋白质组。
  • 复发相关蛋白经免疫组化验证,并在人胶质瘤细胞系、原位异种移植模型和人器官型脑片培养中进一步研究。
  • 分析外部空间转录组、单细胞和批量RNA测序数据以获取机制见解。

主要发现

  • 尽管患者间总体蛋白质组变化异质,鉴定出BCAS1、INF2和FBXO2在复发时持续上调并经免疫组化验证。
  • 在人胶质瘤细胞中敲除FBXO2在原位异种移植小鼠模型中带来强烈生存获益,并减少器官型脑片培养中的侵袭性生长。
  • 在胶质母细胞瘤患者样本中,FBXO2表达在肿瘤浸润区富集,FBXO2阳性癌细胞与突触信号过程相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent efforts have described the evolution of glioblastoma from initial diagnosis to post-treatment recurrence on a genomic and transcriptomic level. However, the evolution of the proteomic landscape is largely unknown. METHODS: Sequential window acquisition of all theoretical fragment ion spectra mass spectrometry (SWATH-MS) was used to characterize the quantitative proteomes of two independent cohorts of paired newly diagnosed and recurrent glioblastomas. Recurrence-associated proteins were validated using immunohistochemistry and further studied in human glioma cell lines, orthotopic xenograft models, and human organotypic brain slice cultures. External spatial transcriptomic, single-cell, and bulk RNA sequencing data were analyzed to gain mechanistic insights. RESULTS: Although overall proteomic changes were heterogeneous across patients, we identified BCAS1, INF2, and FBXO2 as consistently upregulated proteins at recurrence and validated these using immunohistochemistry. Knockout of FBXO2 in human glioma cells conferred a strong survival benefit in orthotopic xenograft mouse models and reduced invasive growth in organotypic brain slice cultures. In glioblastoma patient samples, FBXO2 expression was enriched in the tumor infiltration zone and FBXO2-positive cancer cells were associated with synaptic signaling processes. CONCLUSIONS: These findings demonstrate a potential role of FBXO2-dependent glioma-microenvironment interactions to promote tumor growth. Furthermore, the published datasets provide a valuable resource for further studies.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Buehler M, Yi X, Ge W, et al. Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions. Neuro Oncol. 2023. PMID: 35802605. doi:10.1093/neuonc/noac169

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。